A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates

... Read more

Launches @reignsapphires Social Media and Digital Marketing Campaign in Preparation for The 2016 Holiday Shopping Season

BEVERLY HILLS, CA - October 5, 2016 (Investorideas.com

... Read more

Remark Holdings' 3D Augmented Reality Chosen To Be Core Technology

... Read more

Rent-A-Center, Inc.

... Read more

RetailMeNot Announces First Quarter 2015 Financial Results

... Read more

Retrophin Reports Fourth

... Read more

Revive Therapeutics and South Carolina Research Foundation Enter

... Read more

Rexahn Pharmaceuticals to Present Data on RX-3117 and RX-21101 at the 2014 American Association for Clinical Research Annual

... Read more

RF Industries' First Quarter Sales Jump 56%; Net Income Exceeds Entire

... Read more

RGS Energy Issues Business Update

... Read more